Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Baedeker

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
European Journal of Biochemistry|March 16, 2002
Structures of two histidine ammonia-lyase modifications and implications for the catalytic mechanismMathias Baedeker, Georg E Schulz
Structure (London, England : 1993)|February 14, 2002
Autocatalytic peptide cyclization during chain folding of histidine ammonia-lyaseMathias Baedeker, Georg E Schulz
Nature Reviews. Drug Discovery|January 20, 2026
2025 FDA approvals: volume maintained, but value remains below averageMathias Baedeker, Clemens C Möller
Nature Reviews. Drug Discovery|February 3, 2019
2018 FDA approvals hit all time high - but average value slips againMathias Baedeker, Michael Ringel, Ulrik Schulze
Nature Reviews. Drug Discovery|January 16, 2021
2020 FDA approvals: momentum kept despite COVID-19, but value fallsMathias Baedeker, Michael Ringel, Ulrik Schulze
Nature Reviews. Drug Discovery|February 6, 2020
Value of 2019 FDA approvals: back to the recent averageMathias Baedeker, Michael Ringel, Ulrik Schulze
Nature Reviews. Drug Discovery|January 18, 2022
2021 FDA approvals: value driven by COVID-19 vaccinesMathias Baedeker, Michael S Ringel, Ulrik Schulze
Nature Reviews. Drug Discovery|January 17, 2025
2024 FDA approvals exceed average number but have lower sales projectionsMathias Baedeker, Michael S Ringel, Clemens C Möller
Nature Reviews. Drug Discovery|January 17, 2024
2023 FDA approvals: unprecedented volume at moderate valueMathias Baedeker, Michael S Ringel, Clemens C Möller
Nature Reviews. Drug Discovery|January 20, 2018
Market watch: 2017 FDA drug approvals: number rebounds but average value slipsMathias Baedeker, Michael Ringel, Valery Panier, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
European Journal of Biochemistry|March 16, 2002
Structures of two histidine ammonia-lyase modifications and implications for the catalytic mechanismMathias Baedeker, Georg E Schulz
Structure (London, England : 1993)|February 14, 2002
Autocatalytic peptide cyclization during chain folding of histidine ammonia-lyaseMathias Baedeker, Georg E Schulz
Nature Reviews. Drug Discovery|January 20, 2026
2025 FDA approvals: volume maintained, but value remains below averageMathias Baedeker, Clemens C Möller
Nature Reviews. Drug Discovery|February 3, 2019
2018 FDA approvals hit all time high - but average value slips againMathias Baedeker, Michael Ringel, Ulrik Schulze
Nature Reviews. Drug Discovery|January 16, 2021
2020 FDA approvals: momentum kept despite COVID-19, but value fallsMathias Baedeker, Michael Ringel, Ulrik Schulze
Nature Reviews. Drug Discovery|February 6, 2020
Value of 2019 FDA approvals: back to the recent averageMathias Baedeker, Michael Ringel, Ulrik Schulze
Nature Reviews. Drug Discovery|January 18, 2022
2021 FDA approvals: value driven by COVID-19 vaccinesMathias Baedeker, Michael S Ringel, Ulrik Schulze
Nature Reviews. Drug Discovery|January 17, 2025
2024 FDA approvals exceed average number but have lower sales projectionsMathias Baedeker, Michael S Ringel, Clemens C Möller
Nature Reviews. Drug Discovery|January 17, 2024
2023 FDA approvals: unprecedented volume at moderate valueMathias Baedeker, Michael S Ringel, Clemens C Möller
Nature Reviews. Drug Discovery|January 20, 2018
Market watch: 2017 FDA drug approvals: number rebounds but average value slipsMathias Baedeker, Michael Ringel, Valery Panier, et al.
Pageof 2